Modulation of the firing activity of rat serotonin and noradrenaline neurons by (±)pindolol

Biological Psychiatry

Volumn 45, Issue 9, 1999, Pages 1163-1169

  Haddjeri, Nasser ^a   De Montigny, Claude ^a   Blier, Pierre ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

( )Pindolol; Dorsal raphe nucleus; Locus coeruleus; LSD; MDL 100907; WAY 100635

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LYSERGIC ACID; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PINDOLOL; SEROTONIN 1A ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG ACTIVITY; DRUG ANTAGONISM; INTRAVENOUS DRUG ADMINISTRATION; LOCUS CERULEUS; MALE; NONHUMAN; NORADRENERGIC NERVE; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL;

ACTION POTENTIALS; ANIMALS; LOCUS COERULEUS; MALE; NEURONS; NOREPINEPHRINE; PINDOLOL; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

EID: 0033135315     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00354-0     Document Type: Article

References (37)

1. Aulakh C.S., Wozniak K.M., Haas M., Hill J.L., Zohar J., Murphy D.L. Food intake, neuroendocrine and temperature effects of 8-OH-DPAT in the rat. Eur J Pharmacol. 146:1988;253-259.
2. Baraban J.M., Aghajanian G.K. Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology. 19:1980;355-363.
3. Berman R.M., Darnell A.M., Miller H.L., Anand A., Charney D.S. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression A doubled-blind, placebo-controlled trial . Am J Psychiatry. 154:1997;37-43.
4. Blier P., Bergeron R. The use of pindolol to potentiate antidepressant medication. J Clin Psychiatry. 59:(suppl 5):1998;16-23.
5. 1A receptors produces a rapid antidepressant response. Neuropsychopharmacology. 16:1997;333-338.
6. Blier P., de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci. 15:1994;220-226.
7. 1A agonist gepirone Electrophysiological studies in the rat brain . Synapse. 1:1987;470-480.
8. 1A receptors in dorsal raphe and hipocampus I. Effect spiperone . J Pharmacol Exp Ther. 265:1993;16-23.
9. Bordet R., Thomas P., Dupuis B. Effect of pindolol on onset of action of paroxetine in the treatment of major depression Intermediate analysis of a double-blind, placebo-controlled trial . Am J Psychiatry. 155:1998;1346-1351.
10. Ceci A., Baschirotto A., Borsini F. The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotonergic neurons in rats is attenuated by lesion of the frontal cortex. Neuropharmacology. 33:1994;709-713.
11. 1A autoreceptor. Br J Pharmacol. 124:1998;206-212.
12. 1A receptors in the rat brain. Br J Pharmacol. 123:1998;449-462.
13. Fletcher A., Forster E.A., Bill D.J., et al. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res. 73:1996;337-353.
14. Fornal C.A., Martin F.J., Meltzler C.W., Jacobs B.L. Pindolol suppresses serotonergic neuronal activity (by a WAY 100635-sensitive mechanism) and does not block the neuronal inhibition produced by 8-OH-DPAT in awake cats. Soc Neurosci Abst. 23:1997;386.5.
15. 1A agonist, on the firing of serotonergic dorsal raphe neurons in the rat brain slice. Soc Neurosci Abst. 17:1987;459.6.
16. Gobert A., Rivet J.-M., Cistarelli L., Millan M.J. Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely-moving animals. J Neurochem. 68:1997;1326-1329.
17. Haddjeri N., de Montigny C., Blier P. Modulation of the firing activity of locus coeruleus neurons in the rat by the 5-HT system. Br J Pharmacol. 120:1997;865-875.
18. Haddjeri N., de Montigny C., Curet O., Blier P. Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-HT neurotransmission. Eur J Pharmacol. 343:1998;179-192.
19. Haddjeri N., Seletti B., Gilbert F., de Montigny C., Blier P. Effect of ergotamine on serotonin-mediated responses in the rodent and human brain. Neuropsychopharmacology. 19:1998;365-380.
20. 1A receptors in the rat hippocampus prevent their inactivation by pertussis toxin. Neuroscience. 61:1994;21-30.
21. Hajos M., Richards C.D., Szekely A.D., Sharp T. An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat. Neuroscience. 87:1998;95-108.
22. 1A autoreceptors and the mode of action of selective serotonin reuptake inhibitor (SSRI). Behav Brain Res. 73:1996;281-283.
23. Hoyer D., Schoeffter P. 5-HT receptors Subtypes and second messengers . J Receptor Res. 11:1991;197-214.
24. Lesch K.P., Poten B., Sohnle K., Schulte H.M. Pharmacology of the hypothermic response to 5-HT1A receptor activation in humans. Eur J Clin Pharmacol. 39:1990;17-19.
25. Maes M., Meltzer H.Y. The serotonin hypothesis of major depression. Bloom F.E., Kupfer D.J. Psychopharmacology the Fourth Generation of Progress . 1995;933-944 Raven Press, New York.
26. Maes M., Vandoolaeghe E., Desnyder R. Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression. J Affect Dis. 41:(3):1996;201-210.
27. Meltzer H.Y., Maes M. Effect of pindolol on hormone secretion and body temperature Partial agonist effects . J Neural Transm. 103:1996;77-88.
28. 3H]8-OH-DPAT binding sites in rat cerebral cortex and hippocampus. Neurochem Res. 21:1996;167-176.
29. 1A) receptors. Neuropsychopharmacology. 18:1998;395-398.
30. Perez V., Gilarberte I., Faries D., Alvares E., Artigas F. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet. 349:(9065):1997;1594-1597.
31. 1A receptors In vivo microdialysis and electrophysiological studies in the rat brain . Neuropsychopharmacology. 15:1996;349-360.
32. Seletti B., Benkelfat C., Blier P., Annable L., Gilbert F., de Montigny C. Serotonin, receptor activation by flesinoxan in humans Body temperature and neuroendocrine responses . Neuropsychopharmacology. 13:1995;93-104.
33. Svensson T.H., Bunney B.S., Aghajanian G.K. Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine. Brain Res. 92:1975;291-306.
34. Tada K., Kasamo K., Ueda N., Susuki T., Kojima T., Ishikawa K. Anxiolytic 5-hydroxytryptamine(1A) agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism Single-unit study in unanesthetized, unrestrained rats . J Pharmacol Exp Ther. 288:1999;843-848.
35. Tome M.B., Isaac M.T., Harte R., Holland C. Paroxetine and pindolol A randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency . Int Clin Psychopharmacol. 12:1997;81-89.
36. Zanardi R., Artigas F., Franchini L., Sforzini L., Gasperini M., Smeraldi E., et al. How long should pindolol be associated with paroxetine to improve the antidepressant response. J Clin Psychopharmacol. 17:(6):1997;446-450.
37. Zanardi R., Franchini L., Gaspreini M., Lucca A., Smeraldi E., Perez J. Faster onset of fluvoxamine in combination with pindolol in the treatment of delusional depression A controlled study . J Clin Psychopharmacol. 18:1998;441-446.